ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,384,758, issued on Aug. 12, was assigned to Novartis AG (Basel, Switzerland).
"Crystalline form of LNP023" was invented by Zichen Jia (Reinach, Switzerland), Philipp Lustenberger (Allschwil, Switzerland), Marie Meyer (Hesingue, France) and Massimo Moratto (Basel, Switzerland).
According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein is a crystalline hydrate form of LNP023 hydrochloride and to a process for its preparation. Furthermore, described herein is a pharmaceutical composition comprising the crystalline hydrate form of LNP023 hydrochloride, and at least one pharmaceutically acceptable excipient. The pharmaceutical composition described herei...